Recent Advances in Bacterium‐Based Therapeutic Modalities for Melanoma Treatment

Abstract

Melanoma is one of the most severe skin cancer indications with rapid progression and a high risk of metastasis. However, despite the accumulated advances in melanoma treatment including adjuvant radiation, chemotherapy, and immunotherapy, the overall melanoma treatment efficacy in the clinics is still not satisfactory. Interestingly, bacterial therapeutics have demonstrated unique properties for tumor‐related therapeutic applications, such as tumor‐targeted motility, tailorable cytotoxicity, and immunomodulatory capacity of the tumor microenvironment, which have emerged as a promising platform for melanoma therapy. Indeed, the recent advances in genetic engineering and nanotechnologies have boosted the application potential of bacterium‐based therapeutics for treating melanoma by further enhancing their tumor‐homing, cell‐killing, drug delivery, and immunostimulatory capacities. This review provides a comprehensive summary of the state‐of‐the‐art bacterium‐based anti‐melanoma modalities, which are categorized according to their unique functional merits, including tumor‐specific cytotoxins, tumor‐targeted drug delivery platforms, and immune‐stimulatory agents. Furthermore, a perspective is provided discussing the potential challenges and breakthroughs in this area. The insights in this review may facilitate the development of more advanced bacterium‐based therapeutic modalities for improved melanoma treatment efficacy.